Iron Deficiency in Cardiovascular Disease - Diagnosis, Clinical Implications, and Future Directions

Fraser John Graham1,2, Gabriele Masini3, Samira Lakhal-Littleton4

  • 1School of Cardiovascular and Metabolic Health, University of Glasgow.

Insights

Iron deficiency (ID) is common in cardiovascular disease (CVD) patients, worsening outcomes. Current diagnostic criteria for ID in CVD are inconsistent, impacting research and treatment strategies.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Hematology

Background:

  • Iron is vital for cellular function and oxygen transport.
  • Iron deficiency (ID) is the most prevalent nutrient deficiency globally.
  • ID in cardiovascular (CV) disease patients correlates with adverse outcomes and reduced quality of life.

Purpose of the Study:

  • To review current diagnostic criteria for iron deficiency in cardiovascular disease.
  • To analyze the impact of inconsistent criteria on research findings.
  • To identify areas for future research in defining and managing ID in CV disease.

Main Methods:

  • Literature review of studies and guidelines defining iron deficiency.
  • Analysis of how differing criteria affect observational and trial results.
  • Synthesis of findings to propose future research directions.

Main Results:

  • Inconsistent definitions of iron deficiency exist across studies and guidelines for cardiovascular patients.
  • Varied criteria complicate the interpretation of research data and clinical trial outcomes.
  • Lack of universal acceptance for diagnostic criteria hinders consistent management.

Conclusions:

  • Standardized criteria are needed to accurately define and diagnose iron deficiency in cardiovascular disease.
  • Consistent diagnostic approaches will improve research validity and patient care.
  • Further research is required to establish universally accepted diagnostic benchmarks for ID in CV populations.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
71
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
355
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
226
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
39
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
301
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
40